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ABSTRACT 
Nanotechnology is a broad and novel technology related to all branches of science. However, in the Pharmaceutical industry, it plays an immense 
role in the drug delivery system. Nanotechnology applied on metal-based drug delivery systems varies; the size ranges from 100 nm or less. Metallic 
nanoparticles are existing the world from the 4th century. The noble metals, like gold and silver have attracted many researchers in the class of 
anticancer and anti-microbial. Metallic nanoparticles are not only used in the biomedical applications also have major functions in the domain of 
textiles, agriculture, photography, etc. Various metals are found in various applications in the biomedical industries. At the same time, the metallic 
nanoparticles have been evidences of remarkable toxicity in various studies. The rationale behind this topic was that the properties, applications 
and toxicity of individual metal nanoparticles. As this study have not been compiled and reported. So, in the current review, the gap was filled. The 
main sources for the preparation of the manuscript are Pubmed, Elsevier and google scholars. Keywords used includes metallic nanoparticles, 
reported toxicity of metals in drug delivery, applications of metals in drug delivery, history of novel metals in drug delivery, etc. Approximately 400 
reviews and academic papers were reviewed to compose the manuscript and sorted by reference to the need for a manuscript. 
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INTRODUCTION 
Throughout research as well as in normal life, nanoscience and 
nanotechnology have become familiar terms. The development of 
nonmaterial’s started shortly after the Creation of the universe when 
early meteorites used to develop nanoparticles and nanostructures 
[1]. Nanotechnology applies to the metals-specific branch of science 
and engineering, which has dimensions in the order of 100th of nm or 
less [2]. Nanoparticles commonly used in the biotechnology measure 
of particle size between 10 and 500 nm, rarely reaching 700 nm. Nano 
size of these particles allows for specific interactions with 
biomolecules on the cell surfaces and inside the cells in ways that can 
be described and assigned to the specific biochemical and 
physicochemical properties of such cells [3]. Nanomaterials is 
components with at least one dimension having the scale<100 nm. 
Now, Nanomaterials is an attractive field in medicine and agriculture, 
the discovery of nanomaterial has introduced a new field of science 
called nanotechnology, a concept that was first used by noriotaniguchi, 
a Japanese scientist from Tokyo University [4]. Nanoparticles are 
extremely attractive for several biomedical applications. Due to their 
capability to interact with the molecular or cellular process and the 
possibility to influence their functions [5]. Different types of 
nanoparticles used in pharmaceutical nanotechnologies are polymer 
nanoparticles, liposomes, dendrimers, polymer-drug conjugates and 
antibody-drug conjugates. Pharmaceutical nanotechnology typically 
classifies sustained and controlled delivery systems, stimulus-sensitive 
delivery system, and multifunctional system for combined therapeutic 
delivery, biosensing, diagnostics and site specific drug delivery [6]. 
The term metal nanoparticle is used to describe nano-sized metal with 
dimensions (length, width or thickness) within the size range 1-100 
nm. Metal is substances with high malleability and the luster of 
electrical conductivity that willingly lose their electrons to form 
cations. Metal is naturally present in the Earth's crust and their 
distribution varies from one locality to another, resulting in spatial 
differences in the surrounding concentration [7]. Metallic 
nanoparticles have special properties, such as phonon surface 
resonance and optical properties. Metallic nanoparticles have shown 
various properties in the field of nanotechnology and have enabled 
certain new pathways in nanotechnology. Metallic nanoparticles have 
necessary functional groups. It can be produced and altered so that 
they can link to ligands, antibodies and drugs [8]. Noble metal, 
especially silver and gold, has attracted a great deal of attention from 
researchers in various fields of science and technology, such as 
catalysis, photography, the healthcare industry as anti-cancer and anti-
microbial agents [9]. Priyadhashini KC, et al. studied an antimicrobial 
and anticancer activity of silver nanoparticles from edible mushroom 
and the authors intends to present green synthesis of silver 
nanoparticles and their application as antimicrobial and anticancer 
agents. [10]. DA Silva et al. studied recent advances in the use of 
metallic nanoparticles with anti-tumoral action and the authors are 
summarized the anti-tumor activities of 78 papers of various metallic 
nanoparticles, particularly the one’s containing copper, gold, iron, 
silver and titanium in their composition [11].  
Specifically, functionalized nanoparticles, such as metallic 
nanoparticles can overcome such weaknesses of conventional 
therapies, such as low water solubility or lack of target specificity [12]. 
Optical properties of metal nanoparticles had been studied in great 
detail. Investigations on optical properties, reason bridge gap between 
an atom property and a bulk material. Metal nanoparticles have 
unique properties, which are significantly dependent on their scale, 
shape, composition and dielectric constant [13-15]. This study is 
mainly focused on the various metals used in the pharmaceuticals and 
their properties, toxicity and applications of the metallic nanoparticles. 
History and development 
The strengthening of ceramic matrixes through the incorporation of 
natural asbestos nanofibers more than 4500 y ago [16]. There are 
natural sources such as rocks, plants, and animals also create all 
kinds of natural nanomaterials [17]. Nanoparticles have a long 
history. The gold metal, first mined near Varna in 5th millennium B. 
C. Artisans used nanoparticles, the popular Lycurgus cup made from 
dichloric glass as far back as Rome in the 4th century, as well as in 
the 9th century in Mesopotamia to generate a glittering effect on the 
surface of objects [18]. Michael Faraday, who first turned to metallic 
nanoparticles for beautiful stained glass in color. And, in his 
groundbreaking paper in 1857, he introduced the scientific jargon 
for the optical properties of nanometer-scale metals [19]. It is well 
established that a remarkable shift in properties takes place when 
thin leaves of gold or silver are placed on the glass and heated to a 
temperature well below a red heat (~500 ᵒC) [20]. Metallic film 
consistencies are broken. The implication is perhaps that white light 
is now transferred freely, reflections are depleted correspondingly, 
the electrical resistivity is increased tremendously [21]. Nearly 100 
y later Turkevich et al. used microscopic electronic investigations to 
demonstrate that the ruby-colored colloids developed by Faraday's 
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preparatory routes contain gold particles with average sizes of 6±2 
nm [22]. Colloidal silver was first synthesized in 1880s by Mathew 
Carey Lea of Philadelphia. In the 20th century, colloidal silver was 
commonly used in the photographic film industry, found by X-ray 
diffraction to be metallic silver [23]. Carey Lea colloidal silver 
normally scales 7-10 nm [24]. In 1902, Alfred C. Barnes invented 
Argyrol, a new silver antiseptic drug, derived from the Greek word, 
silver Argyros. It plays a significant role in wiping out infection in 
the upper respiratory tract. No ciliary toxicity, no systemic toxicity 
and no pulmonary risks were reported [25]. Silver has a lot of 
medicinal benefits and treats a variety of diseases. This has both 
antiseptic and antibacterial properties. In 1890, the bacteriologist 
Robert Koch discovered that K [Au (CN) 2] potassium gold cyanide 
had anti-microbial activity against the Tubercle bacillus at small 
concentrations and from there gold is used in modern medicine [26]. 
Michel Peyrone synthesized cisplatin (platinum, which contains anti-
cancer drugs) in 1845 [27]. Alfred Werner elucidated the structure 
of cisplatin in 1893 thus, Roserberg studied the function of cisplatin 
for antitumor. Gold nanoparticles were used in the 17th and 19th 
centuries to treat fever and syphilis [28], respectively. In the late 
1960s, Moyer and Monafo developed 0.5 percent silver nitrate 
solution to treat burn wounds [29]. The copper and zinc complexes 
have been used to treat numerous diseases, including inflammatory 
and degenerative diseases [30]. For the first time Paracelsus used 
zinc sulfate in his prescription, which pioneered the biomedical field 
for the application of zinc-based drugs in therapeutic applications. 
Ancient Romans and Greeks have used copper and copper 
compounds to deal with burns, cough and ear infection. In 1832, 
copper was considered to be able to improve immunity against 
cholera. These have also been commonly used to treat anemia, 
eczema, syphilis, tuberculosis, etc., [31, 32]. Further, the newest 
material, titanium and its alloys are employed in biomedical 
applications, including dentistry [33]. 
Nobel metals in nanoparticles 
Nanoparticles of metal or metal oxides are considered as metallic 
nanoparticles. These approaches are used widely for therapeutic 
applications, diagnostic applications and other fields like optics, 
photophysics, catalysis, electronic and magnetic materials. Owing to 
their relatively high chemical activity and association specificity, 
they have gained substantial interest in the last few years. 
Nanoparticles have distinctly different physicochemical properties 
with metal nanoparticles compared to their voluminous 
counterparts due to their large surface-to-volume ratio, including 
most of the highly active undisciplined metal sites [34]. Metal 
nanoparticles are predominantly used for medical purposes as 
carriers of biomolecules (drugs, peptides, antibodies, nucleic acid, 
aptamers, etc.,). Metal nanoparticles are submicron-scale entities 
made of pure metals such as gold, platinum, silver, titanium, zinc, 
cerium, iron and thallium or their derivatives of oxides, hydroxides, 
sulfides, phosphates, fluorides, and chlorides [35] 
Metal nanoparticles themselves have been commonly used as 
targeted therapy for many diseases such as cancer, cardiovascular 
disease, diabetes, retinal disorders, a neurodegenerative disorder, 
microbial infections, etc. also used for the delivery 
of biomolecules [36]. In this article focuses on the noble metals and 
their properties, applications, and toxicity. 
Gold nanoparticles 
Metallic nanoparticles have been highly utilized for biomedical 
applications. Of various nanoparticle, gold nanoparticles (AuNPs) 
have provoked considerable attention due to their unique optical 
properties. Much research has examined the optical characteristics 
of AuNPs with various sizes and shapes over the last two decades. 
Au NPs' special optical properties emerge from the effect of size 
confinement [37] and the intense, vibrant color of a colloidal gold 
solution caused by the absorption of surface plasmon resonance 
(SPR) [38]. AuNPs band surface plasmon resonance (SPR) and their 
significant physical properties depend on their morphology, such as 
shape, solvent, surface ligand, core power, temperature, and 
physiology [39]. Au NPs can be used as tools for the detection of 
single-molecule surface-enhanced Raman scattering (SERS) [40]. 
Due to their specific characteristics, AuNPs have received significant 
engross from distinct areas of science: high X-ray absorption 
coefficient, ease of structural manipulation, specific control of the 
physical and chemical properties of the particles [41], extreme 
binding affinity to thiols, disulfides and amines [42], remarkable 
optical adjustable and unique electronic properties [43]. 
Applications of AuNPs 
Significant features of AuNPs used in photodynamic therapy (PDT) 
include selective fluorescence quenching and SPR absorption. The 
PDT used for oncological diseases and other skin or infectious 
diseases employs photosensitizers as light-sensitizing agents and a 
laser [44]. AuNPs have gained primary importance as an x-ray 
contrast agent because it represents a high coefficient of X-ray 
absorption, ease of synthetic processing, non-toxicity, colloidal 
stability and targeted delivery surface functionalization [45]. 
Further, AuNPs are active Nanocarriers for theranostic drugs such as 
peptides, proteins [46, 47], plasmid DNAs (pDNAs), small interfering 
RNAs (siRNAs), and chemotherapy agents. Besides, Nanorods and 
nanocages of colloidal gold are good candidates for drug delivery. 
AuNPs have been applied to detect various analytes such as metal 
ions, anions and molecules such as saccharides, nucleotides, 
proteins and toxins as effective sensors [48].  
Toxicity of AuNPs 
AuNPs are typically considered non-toxic, inert and biocompatible 
as bulk gold. Indeed, Various studies have been reported that AuNPs 
cause adverse effects when cells pick them up and preserve them 
because these nanoparticles can transform into potent catalysts. 
According to the research of Yan-Peng Jia et al., The study concluded 
that gold nanoparticles are toxic when it's used in biological systems 
at certain concentration levels. Also, they have summarized from in 
vitro work that gold nanoparticles also induce endogenous reactive 
oxygen species (ROS) development after entering the cells, leading 
to additional oxidative stress-related cytotoxicities, such as DNA 
damage, cell death (apoptosis and necrosis) and consequent cell 
cycle arrest. ROS is thus among the basic function, which causes the 
harmful effects [49]. Another research found that AuNPs cause 
damage to DNA, confirming their genotoxicity [50]. Oxidation of 
protein and polyunsaturated fatty acid, eventually leading to a 
deliberate alteration in mitochondrial function, which is the primary 
cause of cell death. With the aid of DiOC6(3) dye, mitochondrial 
damage caused by spherical PEG-AuNPs on K562 cells after 24-72 h 
treatments were assessed by monitoring changes in the capacity for 
mitochondrial transmembrane [51]. In addition, AuNPs induces 
toxic material leakage due to pH variations, cell damage due to being 
contacted with membrane lipids and proteins, endocrine 
disturbance, gene expression modification, cellular morphology 
changes [52]. 
Silver nanoparticles 
Silver nanoparticles (AgNPs) are nanoparticles of silver, in the range 
of 1 to 100 nm. Silver nanoparticles have remarkable properties that 
aid in molecular diagnostics, medications, and instruments used in 
various medical procedures. It has been well known that silver ions 
and silver related compounds are highly toxic to micro-organisms 
including 16 major bacterial species [53]. Silver nanoparticles are 
extremely efficient to absorb and scatter light, depending on the 
particle surface size, the shape of the particle and the refractive 
index. The strong interaction of silver nanoparticles with light 
occurs because, when excited by light at specific wavelengths, the 
conduction electrons on the metal surface undergo a collective 
oscillation called a surface plasmon resonance (SPR), this oscillation 
results in extremely strong dispersion and absorption properties. As 
particles of aggregate, the optical properties of silver nanoparticles 
changes and the conduction electrons near each particle surface are 
delocalized and shared by neighboring particles. As this happens, 
the frequency of the surface plasmon changes to lower energy, 
allowing the peaks of absorption and dispersion to shift to longer 
wavelengths. UV-Visible spectroscopy can be used to track the 
stability of nanoparticle solutions as an easy and reliable tool [54, 
55]. It is a known fact that the shape of silver nanostructures can 
influence its physical and chemical properties drastically. Silver 
nanostructures commonly used for biomedical applications include 
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silver spherical nanoparticles, nanowires, nanorods, nanoplates and 
nanotubes [56]. 
Applications of AgNPs 
AgNPs function as an antibacterial is wide-ranging, affecting gram-
positive as well as gram-negative bacteria [57]. Silver nanoparticles 
work on and penetrate the bacterial cell wall, causing structural 
changes in the cell membrane such as cell membrane permeability and 
cell death or by releasing silver ions via nanoparticles, these ions can 
interact with and inactivate the thiol groups of many essential 
enzymes [58]. Then, there is the production of reactive oxygen species, 
likely created by silver ions inhibiting a respiratory enzyme and 
attacking the cell itself. AgNPs have also been shown to suppress HIV-
1, Tacaribe virus (TCRV), hepatitis B virus (HBV), recombinant 
respiratory syncytial virus (RSV), the monkeypox virus, murine 
rotavirus (MNV)-1, and influenza A/H1N1 virus. This is usually 
observed as strong radiosensitizers and/or photo-sensitizers. It has 
been stated that grapheneoxide@Ag-doxorubicin-DSPE-PEG2000-
NGR (GO@Ag-DOX-NGR) exhibits excellent chemophotothermal 
therapeutic efficacy, tumor-targeting properties, laser-controlled drug 
release functions of NIR and in vivo murine tumor model X-ray 
imaging capability [59]. The AgNPs have shown promising effects on 
antitumors. Low concentrations of AgNPs have been documented to 
cause DNA damage and chromosomal aberrations (genotoxicity), 
although no significant cytotoxicity has been recorded [60]. 
Toxicity of AgNPs 
The deleterious effects of free silver ions on humans and all life 
forms entail severe bluish-gray discoloration of the skin (argyria) or 
eyes (argyrosis) and exposure to soluble silver compounds can 
result in toxicity such as damage to the liver and kidneys; 
Inflammation of the eyes, skin, respiratory and intestinal tract; and 
unfavorable changes in blood cells [61]. Al Gurabi et al., studied Ag 
nanoparticles were studied with in vivo in various organs such as the 
liver, kidney, lungs, spleen and brain in different subjects, after 
exposures by inhalation or subcutaneous injection. Silver 
nanoparticles has demonstrated more toxicity in terms of cell 
viability, lactate dehydrogenase leakage and production of reactive 
oxygen species (ROS) compared with other nanoparticles [62]. 
Platinum nanoparticles 
Platinum nanoparticles (PtNPs) are usually within the sort of 
suspension or colloid of nanoparticles of platinum during a fluid, 
usually water. Physical properties of pt Nps such as brownish red or 
black color, spherical, rod, cubes and tetrahedral in shape. Size is 
about 2 and 10 nm [63, 64]. 
Applications of PtNPs 
Platinum-based nanomaterials have been shown as excellent 
therapeutic agents [65]. Platinum compounds such as cis-platin, 
carboplatin and oxaliplatin are frequently used in chemotherapy, 
especially in the treatment of ovarian and testicular tumors [66]. 
Since platinum group compounds are cytotoxic, tea capped platinum 
nanoparticles were investigated for his or her toxic behaviour 
towards human cancer cells. It was also important to examine if 
these are toxic to both the healthy and cancer cells, similar to the 
platinum complexes such as cis-platin and carboplatin used in the 
treatment of cancer. They have many side effects like nausea, 
vomiting, nephrotoxicity, neurotoxicity, ototoxicity, hematuria and 
alopecia. Cervical cancer cells (SiHa) were, therefore, treated with 
different concentrations of tea capped platinum nanoparticles. The 
influence on cell viability, nuclear morphology and cell cycle 
distribution showed that the proliferation of SiHa cells was inhibited 
by platinum nanoparticles. The tea polyphenol capped platinum 
nanoparticles exhibited excellent viability at a concentration 
between 12.5 and 200 μgml−1 for twenty-four and 48 h. A 
significant dose-dependent decrease in cell viability was noticed 
with increasing concentration of nanoparticles. When the 
concentration is enhanced, the area is additionally enhanced 
alongside the massive size of the tea polyphenol. The particle size 
and their agglomeration are equally responsible for the cytotoxicity 
of platinum nanoparticles [67]. Although platinum alloys have been 
used in the coronary artery disease, neuromodulation devices and 
catheters, [68] they're not selective for cancer because they 
influence both the traditional cells and cancer cells, resulting in 
many complications. Functioned platinum nanoparticles have shown 
size_ and shape_dependent specific and selective therapeutic 
properties [69, 71]. In many cases, platinum nanoparticles 
containing other organic substances have also been used as 
pro_drug [65, 72]. Manikandan et al. [73] have shown that tiny 
platinum nanoparticles (5–6 nm) are biocompatible and exhibit 
apoptosis-inducing properties [74, 75]. This ability is enhanced 
manifold when they are coated with polymers or fortified with 
phytochemicals. For instance, the herbal extracts, generally used for 
green synthesis of nanoparticles, contain phenol, sugar and acids, 
which act as reducing as well as stabilizing agents. Such 
phytochemicals in combination with cis_platin synergism apoptosis 
in breast cancer and cervical cancer [63, 67, 76]. A combination of 
platinum nanoparticles with ion irradiation has been found to 
enhance the efficiency of cancer therapy [77]. 
Toxicity of PtNPs 
Toxicity stemming from platinum nanoparticles can take multiple 
forms. One possible interaction is cytotoxicity or the power of the 
nanoparticle to cause necrosis. A nanoparticle can also interact with 
the cell’s DNA or genome to cause genotoxicity [78]. These effects are 
seen in altered levels of gene expression measured through protein 
levels. Last is the developmental toxicity that can happen in an 
organism's growth. Developmental toxicity looks at the impact the 
nanoparticle has on the expansion of an organism from an embryonic 
stage to a later point. Most nanotoxicology research is done on cyto_ 
and geno_toxicity as both can easily be done in a cell culture lab. 
Platinum nanoparticles have the potential to be toxic to living cells. In 
one case, 2 nm platinum nanoparticles were exposed to 2 differing 
types of algae so as to know how these nanoparticles interact with a 
living system [79]. In both species of algae tested, the platinum 
nanoparticles inhibited growth, induced small amounts of membrane 
damage, and created a large amount of oxidative stress. In another 
study, the researcher tested the consequences of differently sized 
platinum nanoparticles on primary human keratinocytes. The authors 
tested 5.8 and 57.0 nm PtNPs. The 57 nm nanoparticles had some 
hazardous effects, including decreased cell metabolism but the effect 
of the smaller nanoparticles was much more damaging. The 5.8 nm 
nanoparticles exhibited a more deleterious effect on the DNA stability 
of the first keratincoytes than the larger nanoparticles. The damage to 
DNA was measured in individual cells using single_gel electrophoresis 
via the comet assay [80]. 
Nickel nanoparticles 
Nickel nanoparticles (NiNPs) are typically 10_14 nm with specific 
surface area (SSA) within the 30-50m2/g range and also available 
with a mean particle size of 50-100 nm range with a selected surface 
area of approximately 5_10m2/g. NiNPs find potential applications in 
various fields, including electronics, magnetism, technology and 
biomedicine. Optical properties of NPs are highly dependent on the 
size of particles. Magnetic properties of the NiFe2O4 with an inverse 
spinel structure can be explained in terms of the cations distribution 
and magnetization originates from Fe3+ ions at both tetrahedral and 
octahedral sites and Ni2+ions in octahedral sites [63]. 
Applications of NiNPs 
It is employed within the treatment of prostate enlargement so as to 
spice up the function of T_cells and goes to work and perform more 
efficiently. β_sitosterol inhibits neoplastic cell proliferation by 
decreasing the expression of PCNA or signalling. It inhibits the 
secretion of proinflammatory cytokines and tumor. β-sitosterol have 
antinflammatory efficacy inhibiting cholesterol absorption in the 
lower intestine, thereby reducing excess of cholesterol in the blood, 
preventing atherosclerosis [81]. Ahmed AS et al., investigated the 
NiNPs usage on plants. It controls fusarium wilt on lettuce and 
tomato. NiNPs inhibits the mycelial proliferation and aporulation of 
fungal pathogens [82]. 
Toxicity of NiNPs 
A study has shown effects on interleukin on NiNPs, may cause the 
amount of peroxidase and catalase was decreased and 
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malondialdehyde was increased. Interleukin-4 and interferon-Ɣ 
Were cytokines that were significantly increased within the 
experimental group, compared with the controls. Thus, increase of 
interleukin with a rise in nickel oxide nanoparticles could create a 
disturbance within the production of interleukins by impacting the 
system within the body. An identical state of the condition could also 
occur within the case of increased humoral immune reaction [81]. 
Another was reported on the toxicity of NiNPs on continuous 
inhalation. It causes death due to adult respiratory distress 
syndrome (ARDS). Also, it causes acute tubular necrosis [83]. 
Palladium nanoparticles 
The mean diameter of monodispersed palladium nanoparticles (PdNPs) 
might be controlled from 17 to 30Å in a one-step reaction by changing 
the quantity of protective polymer Poly (N-vinyl-2-pyrrolidone) (PVP). 
Palladium may be a rare and valuable that belongs to the platinum group 
elements. It's largely employed as a lively catalyst material in automotive 
catalytic converters but finds also apply within the electronic 
engineering, biomedical and jewelry sectors [64]. 
Applications of PdNPs  
Palladium adsorbs about 1000 times its own volume of hydrogen 
when brought to dull redness. Their catalytic activity is thanks to the 
dissociation of molecular hydrogen into the atomic state: H2 → 2H. 
Palladium nanoparticles doped with Chitosan–graphene are 
employed as a biosensor for glucose estimation [84]. Palladium 
nanoparticles on graphene oxide have also been used as recyclable 
heterogeneous catalyst for the reduction of nitrogen using sodium 
borohydride. Since the recovered catalyst is often used for five 
cycles, it is often used in a large-scale reduction of nitrogenous. It's 
also been utilized in the reduction of methylthionine chloride, azo 
dye and nitrophenol. The nanoparticles exhibited excellent 
degradation of the above dyes and thus, both palladium and 
platinum are extensively utilized in oxidative addition and reductive 
elimination of hydrogen. Platinised asbestos is employed in many 
catalytic [75] reactions. As an example, (i) within the contact process 
for the manufacture of H2SO4, (ii) in Ostwald process for the 
oxidation of NH3 to NO for the manufacture of HNO3, (iii) oxidation 
of methanol to formaldehyde and (iv) decomposition of hydrazine to 
nitrogen and ammonia. Platinum-gold dendrimer-like nanoparticles 
supported on polydopamine graphene oxide reduce nitrophenol to 
aminophenol [85]. The power to catalyze the reduction depends on 
platinum to gold ratios. Palladium nanoparticles are fabricated from 
S. persica root extract, and their catalytic activity was examined 
within the Suzuki coupling reactions of aryl halides with 
benzeneboronic acid in water to biphenyl [86]. The efficiency of the 
conversion rate as a function of your time and yield follows the 
order iodobenzene>bromobenzene>chlorobenzene, although the 
highest conversion occurred within the first 2 min. The palladium 
nanoparticles as catalyst are often successfully reused for less than 
three cycles. In another study, the common myrtle leaf extract was 
used for the assembly of Pd/TiO2 nanoparticles [87]. The authors 
have demonstrated that Pd/TiO2 nanoparticles as a highly efficient, 
stable and recyclable catalyst for the ligand-free Suzuki–Miyaura 
coupling reaction.  
Toxicity of PdNPs 
Exposure to Pd-NPs was reported to induce different toxic effects on 
various cellular models. The assessment of cell viability in human 
colon adenocarcinoma Caco-2 cells and HaCaT keratinocytes, treated 
with Pd-NPs, revealed only minor effects, maybe associated with the 
cellular stress caused by the NP application [88]. On the opposite 
hand, Wilkinson et al. [89] showed that the exposure of primary 
bronchial epithelial cells (PBECs), and lung carcinoma epithelial cells 
(A549) to stimulate the upper and lower tract, respectively, to Pd-
NPs resulted during a concentration-dependent cytotoxicity. Of note, 
PBECs were markedly more suffering from Pd-NPs than A549 cells. 
In line with these findings, apoptosis was induced during a dose-
dependent manner by Pd-NPs in PBECs, but not in A549 cells [89]. 
Nanoparticle chemical composition appeared also applicable to 
work out cellular viability effects since individual PdNPs resulted in 
less cytotoxicity compared to bimetallic Pt-Pd-NPs on human 
epithelial cervical cancer HeLa cells [90]. Such enhanced effect might 
be ascribed to a synergistic action of both components. Also, the sort 
of NP surface coating was shown as a possible influencing factor for 
the Pd-NP toxicological profile. Recent research on the mechanism of 
palladium toxicity suggests high toxicity if measured on an extended 
timeframe and at the cellular level within the liver and kidney. 
Mitochondria seem to possess a key role in palladium toxicity via the 
mitochondrial membrane potential collapse and depletion of the 
cellular glutathione (GSH) level. Until that recent work, it had led to 
believe that palladium was poorly absorbed by the physical body 
when ingested [91]. 
CONCLUSION 
In the present century, metallic nanoparticles are highly demanded 
in the area of drug delivery and drug targeting. In the study of 
natural products, green synthesis of nanoparticles is strongly 
implicated. This review pedestals the development of metallic 
nanoparticles in the area of antimicrobials, anti-cancer, anti-
inflammatory, degenerative diseases, dentistry and immunity 
boosters have paid great attention. In addition, numerous studies, 
evidence cytotoxicity and the additional toxicity profiles is included. 
As metallic nanoparticles have good potential for drug targeting and 
drug delivery, similar toxicity was also raised. So, proper 
understanding and selection of metal could avoid the remarkable 
adverse effects. From the countless research on metallic 
nanoparticles, very few products are existing in the market. Gaps 
from research to market through proper pilot study, development, 
technology, characterization and testing have to be eliminated. As 
far as metal nanoparticles are a great choice for cancer drug 
delivery, with appropriate establishments, sophisticated technology 
in formulating and extensive clinical studies provides the great 
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